Ufp Technologies (UFPT) Non-Current Deffered Revenue (2015 - 2026)
Ufp Technologies (UFPT) posted Non-Current Deffered Revenue of $6.7 million for Q1 2026, up 1.29% on a QoQ basis from $6.7 million in Q4 2025, and up 4.69% year-over-year from $6.4 million in Q1 2025.
Ufp Technologies (UFPT) Non-Current Deffered Revenue (2015 - 2026) Analysis & Trends
Ufp Technologies' Non-Current Deffered Revenue history runs 12 years deep, the most recent figure standing at $6.7 million for Q1 2026.
- Quarterly Non-Current Deffered Revenue rose 4.69% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (up 4.69% YoY) and the FY2025 annual result came in at $6.7 million, up 7.49% from the prior year.
- Non-Current Deffered Revenue was $6.7 million for Q1 2026 at Ufp Technologies, up from $6.7 million in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $6.8 million in Q3 2025 and bottomed at $3.9 million in Q3 2022.
- A 5-year average of $5.5 million and a median of $5.7 million in 2024 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue retreated 4.12% — and 2023, when it rose 29.88%.
- Ufp Technologies' Non-Current Deffered Revenue stood at $4.2 million in 2022, then gained by 29.88% to $5.4 million in 2023, then increased by 14.43% to $6.2 million in 2024, then grew by 7.49% to $6.7 million in 2025, then climbed by 1.29% to $6.7 million in 2026.
- Business Quant data shows UFPT's Non-Current Deffered Revenue at $6.7 million in Q1 2026, $6.7 million in Q4 2025, and $6.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 512.79 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ufp Technologies | 1.82 Bn | 1.80 Bn | 44.36 Mn | 6.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.74 Mn |
| Dec 31, 2025 | 6.66 Mn |
| Sep 30, 2025 | 6.78 Mn |
| Jun 30, 2025 | 6.52 Mn |
| Mar 31, 2025 | 6.44 Mn |
| Dec 31, 2024 | 6.19 Mn |
| Sep 30, 2024 | 6.17 Mn |
| Jun 30, 2024 | 5.82 Mn |
| Mar 31, 2024 | 5.71 Mn |
| Dec 31, 2023 | 5.41 Mn |
| Sep 30, 2023 | 4.89 Mn |
| Jun 30, 2023 | 5.00 Mn |
| Mar 31, 2023 | 4.75 Mn |
| Dec 31, 2022 | 4.17 Mn |
| Sep 30, 2022 | 3.89 Mn |
| Jun 30, 2022 | 4.05 Mn |
| Mar 31, 2022 | 4.46 Mn |
| Dec 31, 2021 | 4.34 Mn |
| Sep 30, 2021 | 4.05 Mn |
| Jun 30, 2021 | 3.98 Mn |